Active Ingredient(s):Methoxy Polyethylene Glycol-epoetin Beta FDA Approved: * November 14, 2007 Pharm Company: *HOFFMAN-LA ROCHE Category:Anemia
Epoetin beta (rINN) /po.tn/ is a synthetic, recombinant form of erythropoietin, a protein that promotes the production of red blood cells. It is an erythropoiesis-stimulating agent (ESA) that is used to treat anemia, commonly associated with chronic kidney failure and cancer chemotherapy.
Epoetin beta is sold under the brand name NeoRecormon, among others. It is on the World Health Organization's List of Essential Medicines.
* May have multiple approval dates, manufacturers, or labelers.